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inTrOducTiOn
The recent rate of advance of PET/CT equipment tech-
nology has led to the everyday use worldwide of many 
variants of detector and software.1,2 Some earlier PET/CT 
scanners (e.g., bismuth germanate (BGO) crystal equip-
ment) allow scanning with or without collimation, that is, 
in 2D or 3D acquisition modes3 and these are more prev-
alent in emerging markets due to healthcare cost factors. 
However, advanced image reconstruction algorithms 
including resolution recovery (RR) with point spread func-
tion modelling or Bayesian reconstruction4 are also in 
widespread clinical use today.
It is frequently necessary to compare standardised uptake 
values (SUV) of a lesion between two scans, for example 
in assessing response to therapy using PERCIST.5 Ideally, 
standardised protocols would be used to ensure compara-
bility between the SUVs; however, it is frequently necessary 
to compare SUVs acquired in 2D and 3D,6 or reconstructed 
with different algorithms. Harmonisation is the process 
by which it is assured that SUVs acquired using different 
scanners or protocols can be compared; if harmonisation is 
not performed there is a risk of misclassification of lesion 
response.
https:// doi. org/ 10. 1259/ bjro. 20190035
Objectives: Harmonisation is the process whereby 
standardised uptake values from different scanners can 
be made comparable. This PET/CT pilot study aimed to 
evaluate the effectiveness of harmonisation of a modern 
scanner with image reconstruction incorporating reso-
lution recovery (RR) with another vendor older scanner 
operated in two- dimensional (2D) mode, and for both 
against a European standard (EARL). The vendor- 
proprietary software EQ•PET was used, which achieves 
harmonisation with a Gaussian smoothing. A substudy 
investigated effect of RR on harmonisation.
Methods: Phantom studies on each scanner were 
performed to optimise the smoothing parameters 
required to achieve successful harmonisation. 80 
patients were retrospectively selected; half were imaged 
on each scanner. As proof of principle, a cohort of 10 
patients was selected from the modern scanner subjects 
to study the effects of RR on harmonisation.
results: Before harmonisation, the modern scanner 
without RR adhered to EARL specification. Using the 
phantom data, filters were derived for optimal harmo-
nisation between scanners and with and without RR as 
applicable, to the EARL standard. The 80- patient cohort 
did not reveal any statistically significant differences. 
In the 10- patient cohort SUVmax for RR > no RR irre-
spective of harmonisation but differences lacked statis-
tical significance (one- way ANOVA F(3.36) = 0.37, p = 
0.78). Bland- Altman analysis showed that harmonisation 
reduced the SUVmax ratio between RR and no RR to 
1.07 (95% CI 0.96–1.18) with no outliers.
conclusions: EQ•PET successfully enabled harmonisa-
tion between modern and older scanners and against 
the EARL standard. Harmonisation reduces SUVmax and 
dependence on the use of RR in the modern scanner.
advances in knowledge: EQ•PET is feasible to harmo-
nise different PET/CT scanners and reduces the effect of 
RR on SUVmax.
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SUV variations can arise from factors like patient preparation, 
scan protocol, data acquisition/processing and image reconstruc-
tion/analysis.7 Such variations are problematic both in clinical 
work and in multicentre clinical trials, where multiple imaging 
systems are used to recruit sufficient patients for statistical power. 
The process of deriving comparable SUVs from different equip-
ment and protocols is termed harmonisation. Controversy exists 
in comparing clinical scans acquired with different advanced 
reconstruction software8–11 that has stimulated debate regarding 
the use of harmonisation schemes.12
Attempts to minimise SUV inconsistencies through harmonisa-
tion strategies have been recommended by various internation-
ally recognised programmes, for example European Association 
of Nuclear Medicine (EANM) Research Ltd (EARL) accredita-
tion13,14 and the Radiological Society of North America’s (RSNA) 
North American Quantitative Imaging Biomarkers Alliance 
(QIBA). Guidelines generally recommend scanning a fillable 
phantom consisting of hot spheres in a colder background, such 
as that designed by the Association of Electrical Equipment and 
Medical Imaging Manufacturers (NEMA) and the International 
Electrotechnical Commission (IEC). EARL recommends a value 
and permissible range for the recovery coefficient (RC) for each 
sphere diameter in the phantom.15 Such approaches have proved 
helpful for achieving harmonisation in clinical trials.
One challenge with such methodology is the potential genera-
tion of a separate image set optimised for harmonisation, distinct 
from the other datasets usually acquired at a centre. This can 
have consequences for scan labelling, identifying which scan to 
report, disk storage/data backup and manpower resources. A 
solution to the challenge of multiple dataset production and asso-
ciated management has been proposed as the “EQ•PET” propri-
etary harmonisation software developed by Siemens (syngo.MM 
Oncology, Siemens Medical Solutions USA Inc., Knoxville, TN, 
United States)16.
EQ•PET allows SUV to be harmonised to baseline scans obtained 
with less spatial resolution (generally on older equipment or soft-
ware). EQ•PET applies a 3D Gaussian filter to images, using a 
filter kernel width (“EQ•PET factor”) derived specifically for the 
particular scanner and protocol in use, that optimally harmon-
ises that scanner and protocol to an agreed standard (e.g., EARL). 
The EQ•PET factor is usually derived using the NEMA / IEC 
phantom and is entered directly into the vendor’s software. 
Smoothing is performed in the background as the original image 
is displayed, and the harmonised SUV is displayed without 
additional image creation. Detectability and harmonisation are 
thus achieved simultaneously. The EQ·PET has been shown to 
product similar results as EARL,17 but without requiring a sepa-
rate reconstruction.
In this pilot study, we aimed to compare the effects of harmon-
isation of images from two scanners of different generations: 
Siemens Biograph- mCT with lutetium oxyorthosilicate (LSO) 
crystals, including the increased axial field of view (Siemens 
“TrueV”) which operates without septa in “3D mode” (“scanner 
A”), and General Electric (GE) (GE Healthcare, Milwaukee, WI, 
USA) Discovery VCT with BGO crystals (“scanner B”), oper-
ated with septa extended between imaging planes in “2D mode”. 
Harmonisation was performed both between each scanner to the 
EARL standard, and also between the two scanners, harmonising 
the newer mCT to the older VCT. A NEMA phantom was used 
to derive EQ•PET filter parameters. The SUVs measured on clin-
ical images from both scanners were then compared, with and 
without harmonisation.
MeThOds and MaTerials
This study does not constitute clinical research according to the 
National Health Service England and was therefore conducted as 
an audit without the need for patient consent or ethical approval.
Phantom data
The NEMA phantom was prepared without the lung insert as 
scatter correction was not a prime concern. Spheres and back-
ground were filled with F-18 FDG solution concentrations of 45 
kBq/ml and 5 kBq/ml respectively, at the time of the first imaging, 
giving a ratio of 9:1 between these phantom compartments.
The phantom was scanned on both scanners using standard clin-
ical imaging protocols. The scanner A protocol consisted of a 3D 
PET acquisition, with 3 min/bed, reconstructed using ordered 
subsets expectation maximisation using time- of- flight infor-
mation (OSEM + TOF), both with and without RR, with two 
iterations, 21 subsets, a 200×200 matrix and a Gaussian 5 mm 
post- filter (referred to hereafter as OSEM + TOF+ RR and OSEM 
+ TOF). The scanner B protocol consisted of a 2D PET acqui-
sition with 4 min/bed, reconstructed using OSEM VuePoint 
with two iterations, 28 subsets, a 128×128 matrix and a 5.14 mm 
post- filter. Standard clinical low- dose CT protocols were used 
for attenuation correction on both scanners. The phantom was 
scanned six times, three times alternately on each scanner, 
starting with scanner B. Both scanners had passed manufac-
turer and nationally approved QA regimes and were serviced at 
recommended periods.18
The following harmonisations were attempted using EQ•PET 
filtering:
1. To harmonise scanner A OSEM + TOF+ RR data to EARL
2. To harmonise scanner A OSEM + TOF data to EARL
3. To harmonise scanner B data to EARL
4. To harmonise scanner A OSEM + TOF+ RR data to 
scanner B data
For each harmonisation, an optimised EQ•PET filter parameter 
was calculated18 and entered into the vendor’s dedicated viewing 
and analysis workstation (syngo.MM Oncology, Siemens Medical 
Solutions USA Inc., Knoxville, TN, United States).
The EARL standard specifies a range in which the RC should 
reside for each phantom sphere diameter. However, in the case 
of scanner A harmonisation to scanner B (case four above), 
no standard upper or lower limits are available to validate the 
harmonisation success. Therefore for consistency we used the 
permitted range for each sphere in the EARL recommendations, 
as a percentage of the RC for that sphere, and applied the same 
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percentage to the scanner B mean RCs to generate a compa-
rable window of acceptance for harmonisation in this case. The 
phantom- derived EQ•PET filters were then used in the next 
section with clinical data.
Clinical data
40 patients with suspected cancer in the head and neck (n = 
10), lung (n = 10), oesophagus (n = 5), colorectum (n = 8) or 
lymphatic system (n = 7) were consecutively selected from the 
scanner A database to investigate the influence of different clin-
ical acquisition parameters on the ability of EQ•PET to harmo-
nise suspected lesion SUVmax. Similarly a second independent 
group of 40 patients with the same number of clinical indications 
were also consecutively selected from the scanner B database 
over the same time period. All 80 patients were imaged using 
routine protocols over a period of approximately 7 months. The 
tracer used was F-18 FDG throughout. Patients were imaged 
90 min after injection.
For scanner A patients, the average ±standard deviation (sd) 
for weight, age, injected activity and blood glucose was 78.22 kg 
±22.98, 64.30 year ±11.66, 347.5 MBq ±97.5 and 6.25 mmol l−1 
± 1.17, respectively. For scanner B patients, equivalent values 
were 77.06 kg ±16.58, 61.74 year ±15.53, 349.58 MBq ±74.84 and 
5.96 mmol l−1 ± 0.92, respectively. For scanner A, data were 
acquired at 3 min/bed, and reconstructions were performed into 
a 200×200 image matrix with two iterations, 21 subsets, TOF and 
RR, and a Gaussian 5 mm post- filter. For scanner B, data were 
acquired at 4 min/bed, and reconstructions were performed into 
a 128×128 image matrix with two iterations, 28 subsets and a 
5.14 mm post- filter. These parameters were originally optimised 
using the NEMA image quality phantom and then checked 
annually for local use and for use in clinical trials.
A subset of 10 scanner A patients comprising head and neck (n 
= 1), lung (n = 5) and lymphoma (n = 4) cancer with a range of 
suspected lesion SUVmax was also arbitrarily selected to investi-
gate the effect of OSEM + TOF+ RR versus OSEM + TOF recon-
struction with and without EARL harmonisation.
Radiologists reported PET/CT scans under usual standard- 
of- care conditions on dedicated vendor- specific workstations 
(syngo.MM Oncology, Siemens Medical Solutions USA Inc., 
Knoxville, TN, United States or GE, ADW). Lesions were identi-
fied by inspection of the images during reporting; clinicians drew 
VOIs and derived lesion SUVmax accordingly. Comparisons were 
made of SUVmax pre- harmonisation and post- harmonisation.
SUVmax distributions were evaluated for normality using 
Shapiro- Wilk test and if necessary log10 transformed creating 
normal distributions allowing one- way analysis of variance 
(ANOVA) to determine statistical significance between distri-
butions. Because distributions were tested for normality, non- 
parametric testing was not used in this analysis. Comparison of 
paired weight, age, injected activity and blood glucose datasets 
between scanners for non- normal patient demographic data was 
evaluated using Wilcoxin- signed ranked test. StatsDirect statis-
tical software package (StatsDirect Ltd. StatsDirect statistical 
software. http://www. statsdirect. com. England: StatsDirect Ltd. 




Table  1 shows EQ•PET filter values calculated for optimum 
harmonisation between scanner B and EARL, scanner A OSEM 
+ TOF+ RR and EARL, scanner A OSEM + TOF and EARL and 
scanner A OSEM + TOF+ RR to scanner B phantom datasets. 
Pre- harmonisation phantom RCs for both scanners, with and 
without RR, compared against the EARL specification are shown 
in Figure  1. Only the scanner A without RR plot adhered to 
EARL limits.
Respective phantom RCs harmonised to the EARL criteria are 
displayed in Figure 2. All three plots lie within the EARL recom-
mended range, indicating that harmonisation was possible in all 
cases for all spheres.
In the case of scanner A harmonised to scanner B (Figure 3), it is 
seen that scanner A data can be harmonised to lie within a range 
based on scanner B data, whose width is (arbitrarily) propor-
tionately that of the EARL recommendations. It is noted in the 
case of the 28 mm sphere the scanner A harmonised RC falls just 
outside the adopted lower limit by a small percentage difference 
of 0.58%.
2. clinical data
40 different patients were imaged on each scanner. For each 
scanner, demographic parameters were investigated, some 
known to influence SUVmax: no significant differences were 
found between paired patient age (p = 0.89), weight (p = 0.96), 
injected activity (p = 0.72) or blood glucose (p = 0.34). There is 
therefore a low probability of bias in results presented here arising 
from variations in patient demographics between scanners.
The clinical effect of scanner A RR with or without harmon-
isation with respect to EARL or scanner B can be seen in the 
box and whisker plot (Figure 4) depicting min – [mean ± sd] – 
max clinical SUVmax distributions from 80 suspected oncology 
patients. This plot also depicts the same information for scanner 
B with or without harmonisation with respect to EARL speci-
fications. One- way ANOVA revealed no statistically significant 
Table 1. Summary of EQ•PET mean filter values for harmoni-
sation between different data sets
Original dataset Harmonised to
EQ•PET
Filter (mm)
Scanner B EARL 6.0
Scanner A RR EARL 5.7
Scanner A no RR EARL 4.9
Scanner A RR Scanner B 3.6
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differences existed between respective datasets (F(4,195) = 0.82, 
p = 0.51).
Figure  5 compares the effect of scanner A with and without 
RR with and without harmonisation against EARL criteria for 
a subset of 10 patients as proof of principle. One- way ANOVA 
revealed no statistically significant differences between respec-
tive datasets (F(3,36) = 0.37, p = 0.78).
For this subcohort Figure 6 plots the scanner A data SUVmax 
with (x- axis) and without (y- axis) RR reconstruction, and both 
with (square) or without (triangle) harmonisation to the EARL 
standard for comparison. A good correlation coefficient is 
achieved both with (r2 = 0.99) or without (r2 = 0.97) harmoni-
sation. The correlation coefficient must be interpreted bearing in 
mind that reconstructions with and without RR derive from the 
same raw data; note although that the level of correlation remains 
high when harmonisation is applied. The equality line shows that 
SUVmax with RR is greater than that without RR, irrespective of 
harmonisation status; however, the slope for harmonised scans 
(0.89) is greater than that for non- harmonised scans (0.76), indi-
cating that with harmonisation there is less effect on SUVmax 
when RR is included in the reconstruction.
Figure 7 depicts the SUVmax relationship between RR and no RR 
ratio, without EARL harmonisation, using Bland- Altman anal-
ysis. The mean ratio was 1.19 (95% CI 0.95–1.42). No outliers 
were observed beyond the 2xSD CI about the mean. Figure  8 
shows the SUVmax relationship between RR and no RR, this 
time with EARL harmonisation. The mean ratio was 1.07 (95% 
CI 0.96–1.18). The lower ratio in  suggests that harmonisation 
diminishes the effect of RR on the SUVmax. Again no outliers 
were observed beyond the 2xSD standard CI about the mean. In 
both cases, a low (<0.2) Pearson’s correlation coefficient indicates 
that there is unlikely to be any correlation with SUVmax.
discussiOn
Harmonising scanners in PET/CT centres with different imaging 
equipment may be of value when scanners have not or cannot be 
harmonised to recommended guidelines like EARL, but pass all 
Figure 1. Recovery coefficients before harmonisation compared to European standard criteria
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required QA regimes for safe use19 and have clinician- approved 
image quality. During scanner downtime, consistency in patient 
SUV may be preserved by scanning on different equipment and 
harmonising SUVs. In addition, harmonisation using modern 
equipment can play a role immediately following replacement of 
older technology, where one may wish to ensure consistency of 
SUV between scanners. EQ•PET harmonisation assists without 
additional dataset creation in such cases.
We successfully harmonised scanner A data with and without RR 
to EARL and scanner B data to EARL at a centre that had PET/
CT national certification but had not applied for EARL accredita-
tion, Figure 2. In principle, using an acceptable RC range derived 
from EARL, we also harmonised scanner A RR data to scanner 
B, although there are some concerns about this expressed in 
other work.20 We found that datasets reconstructed with RR 
yielded higher mean SUVmax values than datasets reconstructed 
without RR, but that this difference was less when harmonisation 
was applied. However, no statistically significant differences in 
SUVmax were observed between scanner A RR, scanner A RR 
harmonised to EARL, scanner A RR harmonised to scanner B, 
scanner B or scanner B harmonised to EARL scanned datasets.
It should be noted that the phantom used for these results did 
not have the lung insert in place, and this might affect the rela-
tionship of 2D to 3D results because the scatter conditions are 
significantly different between the two modalities. This was not 
investigated in this work and is a limitation of the study.
SUVmax comparison of clinical datasets from scanner A, with 
or without RR, and with or without harmonisation was investi-
gated in a subgroup of 10 patients (Figure 5). Mean SUVmax was 
greater when RR was used, irrespective of harmonisation, but 
harmonisation to EARL resulted in a lower mean and sd. This 
again suggests less influence of reconstruction algorithm when 
harmonisation was applied, although no statistically significant 
differences were observed between scanner A RR, scanner A 
RR harmonised to EARL, scanner A without RR or scanner A 
without RR harmonised to EARL scanned datasets.
The findings in Figure 6 confirm those in Figure 5. RR increases 
SUVmax in a subset of 10 suspected oncology patients scanned 
on scanner A, irrespective of harmonisation to EARL, but this 
effect is reduced by harmonisation.
Figure 2. Recovery coefficients after harmonisation compared to European standard criteria
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Figure 3. Recovery coefficients after harmonisation with respect to scanner B adapted from European standard criteria
 
 
Figure 4. Box and whisker plots depicting min – [mean ± standard deviation] – max from 80 patients showing clinical SUV distri-
butions pre- harmonisation and post- harmonisation
7 of 9 birpublications.org/bjro BJR Open;2:20190035
BJR|OpenOriginal research: PET/CT harmonisation of scanners using commercially available software.
(Figures 7 and 8) demonstrate the same thing: in the subset of 10 
patients, the mean ratio of SUVmax with and without RR is closer 
to unity (10.6% lower) when harmonisation is used. The confi-
dence limit is also smaller (72.5% lower) with harmonisation.
The EANM/EARL and EQ•PET harmonisation process applied 
in this pilot study has limitations. Internationally not all PET/
CT scanning centres fully conform to EANM- endorsed imaging 
guidelines but will maintain national QA standards for routine 
and research scans. Here EARL RCs were based on an average of 
three scans. Furthermore, RR reconstruction may be differently 
characterised in simple geometry like the NEMA phantom rather 
than clinically with variable lesion sizes,21 heterogeneous lesions 
and variable background activity distributions including respi-
ratory motion effects. Other filtering techniques and measure-
ment metrics for example SUVpeak, tumour lesion glycolysis 
(TLG) or metabolic tumour volume (MTV) may provide addi-
tional information in this setting and be less sensitive to recon-
struction algorithms,22 and it is a specific limitation of the study 
that only SUVmax is considered. This paper does not consider 
the frequency with which EQ•PET filter parameters should be 
checked; however, it is reasonable to assume that this should be 
done after significant modification to the data acquisition, recon-
struction or image processing.20
There is growing awareness of PET harmonisation techniques, 
particularly involving modern technology operated under EANM 
guidelines against the EARL standard. A recent harmonisation 
study23 used EQ•PET on images from a single scanner, recon-
structed using RR and 3D OSEM, of 50 NSCLC patients. Bland- 
Altman analysis showed that the impact on SUV of the choice 
of reconstruction algorithm could be reduced without adversely 
affecting throughput of reconstruction and image interpreta-
tion. In another study,24 86 non- small cell lung cancer (NSCLC) 
patients were imaged for treatment response assessment using 
three 3D scanners from the same vendor. The authors showed 
that choice of reconstruction algorithm introduced variability 
in PERCIST (PET response criteria in solid tumours) response 
classification, which was minimised by the use of harmonisation 
to EARL with EQ•PET using lean body mass- based SUVpeak.
In a further NSCLC study25 describing different generation 
scanners, different reconstruction parameters were used to 
confirm successful EARL harmonisation via Bland- Altman 
Figure 5. Box and whisker plots depicting min – 
[mean ± standard deviation] – max from 10 patients showing 
clinical SUVmax distributions pre- EARL and post- EARL 
harmonisation with and without RR
Figure 6. Plot of scanner A no RR SUVmax versus RR SUVmax 
showing respective unity (black, dotted), with (red, solid) and 
without (blue, dashed) harmonisation straight line fits plus 
correlation coefficients for 10 patient cohort.
Figure 7. Bland–Altman plot of RR SUVmax versus no 
RR SUVmax for 10 patients on scanner A without EARL 
harmonisation
Figure 8. Bland Altman plot of RR SUVmax versus no RR 
SUVmax for 10 patients on scanner A with EARL harmonisation
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analysis. In a different study,26 517 oncology patients with 
NSCLC, non- Hodgkin lymphoma and metastatic colorectal 
cancer were scanned on three different 3D scanner models but 
from the same manufacturer. Bland- Altman results showed 
EARL harmonisation with EQ•PET was successful for RR, 
TOF and OSEM algorithms using SUVmax, SUVmean and 
SUVpeak.
Another review27 endorsed PET/CT EARL harmonisation meth-
odology using EQ•PET in the oncology therapy setting whilst 
validating accreditation methodology in 51 participating centres. 
In a new publication,20 four modern TOF- enabled and RR- en-
abled 3D PET/CT scanners from three different vendors were 
used to demonstrate that harmonisation of phantom studies to 
EARL specifications could be achieved. However, different RCs 
were advocated and a modification to multicentre accreditation 
was recommended as a consequence of advanced reconstruction 
algorithms.
A recent forward- facing review28 investigated adapting harmon-
isation to other radiopharmaceuticals for example Ga-68- 
PSMA in prostate cancer for lymph node detection. Literature 
also exists relating to advanced image analysis techniques like 
textural analysis29 with PET/CT30 which require consistency 
between SUV acquired under different conditions. In a single 3D 
scanner study31 with 71 lesions in 60 NSCLC patients compa-
rable SUV and heterogeneity information was achieved using RR 
and harmonising with Gaussian smoothing, and then compared 
to simpler OSEM reconstructed scans.
The majority of clinical studies using EQ•PET have been based 
on NSCLC, with Siemens modern 3D scanners using LSO- 
based crystal detector technology. There is little reported about 
harmonisation between truly different generations of PET/CT 
scanner, especially across different vendors.
The retrospective cohort of 80 patients in this study demon-
strated the clinical feasibility of harmonisation between two 
scanners and against the EARL standard. Future studies are 
suggested with larger patient numbers combined with varied 
scanners from different vendors for further analysis of the clin-
ical consequences of harmonisation. We encourage the adop-
tion of the EQ•PET concept to promote harmonisation without 
creation of multiple datasets.
cOnclusiOn
As a PET/CT centre approved for national research studies, we 
have shown in a pilot study that different PET/CT scanners can 
be harmonised using EQ•PET to current EARL specifications. 
Our results are in accordance with others. No statistically signif-
icant differences among 80 suspected oncology patient lesion 
SUVmax with or without harmonisation between scanners was 
observed. Standard clinical protocols with or without RR recon-
struction had lower SUVmax mean and sd following respective 
harmonisation. A subset of 10 patients reconstructed with or 
without RR and with or without harmonisation revealed smaller 
mean and sd in harmonised scans, but again differences were not 
statistically significant. Harmonisation with EQ•PET is shown to 
reduce dependence on reconstruction algorithm in both older 
and modern scanners.
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